Literature DB >> 12604201

Conformational changes and activation of yeast aldehyde dehydrogenase by various agents.

F Mark Dickinson1.   

Abstract

Activity assays are characterised by a slow activation phase lasting 1-2 min which arises from the conversion of the low activity/inactive form of the isolated yeast aldehyde dehydrogenase into a high activity form upon binding NADP(+). When Mg(2+) is present as an activator, the binding of coenzyme is relatively strong and activation is effectively complete when the steady-state rates are measured. Lineweaver-Burk plots with 1/[NADP(+)] as variable are linear. In the absence of Mg(2+), coenzyme binding is relatively weak and the conversion of inactive to active enzyme is not complete when steady-state rates are measured. The balance of equilibrium is now finely balanced and the degree of activation depends on the NADP(+) concentration. Under these conditions, rate versus [NADP(+)] plots are sigmoid, characterised by a Hill coefficient of 1.8 because the active (as opposed to the total) enzyme concentration is different in assays with different [NADP(+)]. Kinetic studies indicate that the activation process involves two steps, but the data do not allow discrimination between alternative mechanisms. Gel filtration and sedimentation equilibrium centrifugation indicate that the activation process does not involve enzyme association-dissociation. Activation of the enzyme can also be achieved by replacing Mg(2+) by small amounts of protamine sulphate, poly-L-lysine or poly-L-arginine. The mechanism for these activations is unknown, but presumably involves the binding of the enzyme to these positively charged molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604201     DOI: 10.1016/s0009-2797(02)00201-6

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  1 in total

1.  Mechanistic characterization of the MSDH (methylmalonate semialdehyde dehydrogenase) from Bacillus subtilis.

Authors:  Claire Stines-Chaumeil; François Talfournier; Guy Branlant
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.